Atenlol
₹1,600.00
Applications
Atenolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and improve survival after a heart attack. Atenolol is in a class of medications called beta blockers.
Description
Atenolol is a second-generation beta-1-selective adrenergic antagonist that reduces heart rate and blood pressure and decreases myocardial contractility. It is FDA-approved and indicated in treating hypertension, angina pectoris, and acute myocardial infarction.
Preparation
Compound 3b (0.43 g, 1.7 mmol) in ethanol (5 cm3) and water (5 cm3) was heated under reflux with the platinum hydration catalyst 4 (1 mg, 2.3 × 10 -6 mol) for 72 h
Chemical Properties
Atenolol is a white to off-white crystalline powder with low solubility in water, known for its beta-blocking properties used in the treatment of hypertension and angina.
Definition
Atenolol is a selective beta-blocker medication used to manage hypertension, angina, and other cardiovascular conditions by slowing the heart rate and reducing the workload on the heart.
Description
| Product Name | Atenlol |
| Grade Standard | Bio-Tech Grade |
| Item Color | WHITE |
| CAS Number | 29122-68-7 |
| Molecular Formula | C14H22N2O3 |
| Country of Origin | Made in India |
| Formula | C14H22N2O3 |
| Boiling Point | 508 DegreeC |
| Molar Mass | 266.336 g/mol |
| CAS ID | 29122-68-7 |
| Melting point | 154°C |
| Density | 1.0807 (rough estimate) |
| refractive index | 1.5110 (estimate) |
| Flash point | 2℃ |
| storage temp. | 2-8°C |
| solubility | H2O: 0.3 mg/mL |
| form | powder |
| pka | 9.6(at 25℃) |
| Water Solubility | 13.5mg/L(25 ºC) |
| Packaging Size | As Per Requirement |
Our Export Location as a Atenlol Manufacturer, Supplier, Exporter, Stockist from India.
 Afghanistan
|
 Bosnia and Herzegovina
|
 Cote d’Ivoire
|
 Schaumburg-Lippe*
|
 India
|
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Austrian Empire
Azerbaijan
Baden
Bahamas
Bahrain
Bangladesh
Barbados
Bavaria
Belarus
Belgium
Belize
Benin (Dahomey)
Bolivia
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mecklenburg-Schwerin
Mecklenburg-Strelitz
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Botswana
Brazil
Brunei
Brunswick and Lüneburg
Bulgaria
Burkina Faso 
Burma
Burundi
Cabo Verde
Cambodia
Cameroon
Canada
Cayman Islands
Central African Republic
Central American Federation
Chad
Chile
China
Colombia
Comoros
Congo Free State
Costa Rica
Morocco
Mozambique
Namibia
Nassau
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North German Confederation
North German Union
North Macedonia
Norway
Oldenburg
Oman
Orange Free State
Pakistan
Palau
Panama
Papal States
Croatia
Cuba
Cyprus
Czechia
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Duchy of Parma
East Germany
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Federal Government of Germany
Fiji
Papua New Guinea
Paraguay
Peru
Philippines
Piedmont-Sardinia
Poland
Portugal
Qatar
Republic of Genoa*
Republic of Korea (South Korea)
Republic of the Congo
Romania
Russia
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Grand Duchy of Tuscany
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Hanover
Hanseatic Republics
Hawaii
Hesse
Holy See
Honduras
Hungary
Iceland
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Texas
Thailand
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kingdom of Serbia/Yugoslavia
Kiribati
Korea
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Lew Chew (Loochoo)
Timor-Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Two Sicilies*
Uganda
Ukraine
Union of Soviet Socialist Republics*
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Württemberg*
Yemen
Zambia
ZimbabweRelated products
-
- Sale!
- API and intermediate
Tranexamic Acid API
- ₹4,300.00
-
- Sale!
- API and intermediate
Pioglitazone Hydrochloride
- ₹7,000.00
-
- Sale!
- API and intermediate
Indapamide
- ₹200.00
Reviews
There are no reviews yet.